Literature DB >> 35094363

Thermal Ablation Treatment for Cervical Precancer (Cervical Intraepithelial Neoplasia Grade 2 or Higher [CIN2+]).

Montserrat Soler1,2, Rachel Masch3, Rakiya Saidu4, Miriam Cremer5,3.   

Abstract

Cervical cancer is a leading cause of mortality for women in low- and middle-income countries (LMICs). Invasive disease can be prevented through the treatment of high-grade cervical precancer lesions. Types of treatment for cervical precancer include excisional procedures that surgically remove the affected tissue and ablation treatments which utilize extreme temperatures to destroy precancerous cells. Excision is the first-line treatment in higher income countries, but requires specialized training and equipment that make it unsuitable for low-income settings. The most common treatment globally is cryotherapy, which utilizes cryogenic gas to freeze the area. However, the need for gas presents significant procurement and logistical challenges. The World Health Organization (WHO) has recently endorsed the use of thermal ablation, a method that utilizes heat to destroy precancerous tissue. This review describes three existing thermal ablation devices and protocols for their use, including step-by-step instruction guides to perform a successful treatment with each device and observations specific to each machine.
© 2022. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  CIN2+; Cervical intraepithelial neoplasia; Cervical precancer; Cold coagulation; LMIC; Thermal ablation; Thermocoagulation

Mesh:

Year:  2022        PMID: 35094363     DOI: 10.1007/978-1-0716-1811-0_46

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  10 in total

1.  Success rate of cold coagulation for the treatment of cervical intraepithelial neoplasia: a retrospective analysis of a series of cases.

Authors:  William Parry-Smith; Martyn Underwood; Sabrina De Bellis-Ayres; Laura Bangs; Charles W E Redman; Jane Panikkar
Journal:  J Low Genit Tract Dis       Date:  2015-01       Impact factor: 1.925

2.  Comparison of cure rates in women treated with cold-coagulation versus LLETZ cervical treatment for CIN2-3 on pretreatment cervical punch biopsies: a retrospective cohort study.

Authors:  Dimitrios Papoutsis; Martyn Underwood; William Parry-Smith; Jane Panikkar
Journal:  Arch Gynecol Obstet       Date:  2017-02-22       Impact factor: 2.344

3.  Efficacy, safety, and acceptability of thermocoagulation for treatment of cervical intraepithelial neoplasia in a hospital setting in Brazil.

Authors:  Paulo S V Naud; Richard Muwonge; Eduardo P Passos; Valentino Magno; Jean Matos; Rengaswamy Sankaranarayanan
Journal:  Int J Gynaecol Obstet       Date:  2016-03-02       Impact factor: 3.561

4.  Implementation of 'see-and-treat' cervical cancer prevention services linked to HIV care in Zambia.

Authors:  Mulindi H Mwanahamuntu; Vikrant V Sahasrabuddhe; Krista S Pfaendler; Victor Mudenda; Michael L Hicks; Sten H Vermund; Jeffrey S A Stringer; Groesbeck P Parham
Journal:  AIDS       Date:  2009-03-27       Impact factor: 4.177

Review 5.  Meta-analysis of the efficacy of cold coagulation as a treatment method for cervical intraepithelial neoplasia: a systematic review.

Authors:  L Dolman; C Sauvaget; R Muwonge; R Sankaranarayanan
Journal:  BJOG       Date:  2014-03-06       Impact factor: 6.531

Review 6.  Worthy of further consideration: An updated meta-analysis to address the feasibility, acceptability, safety and efficacy of thermal ablation in the treatment of cervical cancer precursor lesions.

Authors:  Thomas C Randall; Catherine Sauvaget; Richard Muwonge; Edward L Trimble; Jose Jeronimo
Journal:  Prev Med       Date:  2018-10-17       Impact factor: 4.018

7.  Effectiveness, safety and acceptability of 'see and treat' with cryotherapy by nurses in a cervical screening study in India.

Authors:  R Sankaranarayanan; R Rajkumar; P O Esmy; J M Fayette; S Shanthakumary; L Frappart; S Thara; J Cherian
Journal:  Br J Cancer       Date:  2007-02-20       Impact factor: 7.640

8.  Feasibility of thermocoagulation in a screen-and-treat approach for the treatment of cervical precancerous lesions in sub-Saharan Africa.

Authors:  Manuela Viviano; Bruno Kenfack; Rosa Catarino; Eveline Tincho; Liliane Temogne; Anne-Caroline Benski; Pierre-Marie Tebeu; Ulrike Meyer-Hamme; Pierre Vassilakos; Patrick Petignat
Journal:  BMC Womens Health       Date:  2017-01-07       Impact factor: 2.809

9.  Efficacy of thermoablation in treating cervical precancerous lesions in a low-resource setting.

Authors:  Phuong Lien Tran; Bruno Kenfack; Eveline Tincho Foguem; Manuela Viviano; Liliane Temogne; Pierre-Marie Tebeu; Rosa Catarino; Anne-Caroline Benski; Pierre Vassilakos; Patrick Petignat
Journal:  Int J Womens Health       Date:  2017-12-01

10.  Use of thermo-coagulation as an alternative treatment modality in a 'screen-and-treat' programme of cervical screening in rural Malawi.

Authors:  Christine Campbell; Savel Kafwafwa; Hilary Brown; Graeme Walker; Belito Madetsa; Miriam Deeny; Beatrice Kabota; David Morton; Reynier Ter Haar; Liz Grant; Heather A Cubie
Journal:  Int J Cancer       Date:  2016-05-04       Impact factor: 7.396

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.